<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
AMEX:OCX (USA) Also Trade In: Germany UK

OncoCyte Corp $ 1.7 0.01 (0.59%)

Volume:
98,981
Avg Vol (1m):
206,754
Market Cap $:
88.35 Mil
Enterprise Value $:
53.12 Mil
P/E (TTM):
0.00
P/B:
2.63
Warning! GuruFocus has detected 1 Severe warning sign with OCX. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

6.6/10
Current Vs Industry Vs History
Cash-To-Debt 32.63
Debt-to-Equity 0.03
Debt-to-EBITDA -0.07
N/A
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
ROIC 0%
WACC 31.79%

Profitability

3/10
Current Vs Industry Vs History
ROE % -93.41
ROA % -73.35
ROC (Joel Greenblatt) % -2899.82
3-Year EBITDA Growth Rate 1.2

Ratios

Current Vs Industry Vs History
PB Ratio 2.63
EV-to-EBIT -3.23
N/A
EV-to-EBITDA -3.32
N/A
Current Ratio 9.13
Quick Ratio 9.13

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.2

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 2.62
Earnings Yield (Greenblatt) % -31.16